Skip to Content Skip to Footer
John Andraos, PharmD, APh

John Andraos, PharmD, APh

Assistant Professor

College of Pharmacy

jandraos@westernu.edu

  • Education
    • PharmD 2019, Chapman University School of Pharmacy
    • Pharmacy-Based Travel Medicine, American Pharmacist’s Association, 2019
    • Teaching Certificate, Chapman University School of Pharmacy, 2020
    • APh (Advanced Practice Pharmacist), 2022
    • BCACP (Board Certified Ambulatory Care Pharmacist), 2023
  • Education Experience
    • PGY1 Residency Ambulatory Care Focused Pharmacy Practice 2020, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
    • PGY2 Ambulatory Care (Endocrinology) and Academia Focused 2021, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
  • Professional Experience
    • Clinical Pharmacist, Resident Coordinator, Cedars Sinai Medical Network 2021-2022
    • Adjust Assistant Professor of Pharmacy, Chapman University School of Pharmacy 2019-2022
    • Adjust Assistant Professor of Pharmacy, Touro University California College of Pharmacy, 2021-2022
  • Awards
    • CSHP Innovating Pharmacy Practice Award, 2020
    • CUSP Resident Teacher of the Year Award, 2019-2020
    • American Association of Colleges of Pharmacy Walmart Scholar, 2019
  • Organizations
    • California Pharmacy Student Leadership (CAPSLEAD)
    • American Society for Preventative Cardiology (ASPC)
    • The Association of Diabetes Care and Education Specialists (ADCES)
    • American College of Clinical Pharmacy (ACCP)
    • American Association of Colleges of Pharmacy (AACP)
    • American Heart Association (AHA)
    • Obesity Medicine Association (OMA)
    • Phi Delta Chi
    • Phi Lamda Sigma
    • Rho Chi
  • Publications
    • Symptoms Related to Ears, Nose, and Throat (book chapter). Patient Assessment for Pharmacists. In progress.
    • Andraos J, Smith S, Tran A, Pham D. Narrative Review of Data Supporting Alternate First-Line Therapies Over Metformin in Type 2 Diabetes. Nature Reviews Endocrinology. Journal of Diabetes & Metabolic Disorders. March 2024.
    • Andraos J, Muhar H, Smith S. “Beyond Glycemia – Comparing Tirzepatide to GLP-1 Analogues.” Reviews in Endocrine and Metabolic Disorders. August 2023.
    • Zeiger A, Andraos J, Sharma A, Roosan M. “Pharmacogenomic Considerations in Opioid Therapy”. U.S. Pharmacist. April 2022.
    • John Andraos, Luma Munjy &; Michael S. Kelly (2021): Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations, Blood Pressure, DOI: 10.1080/08037051.2021.1911622
    • Kelly M, Andraos J, Zeiger A. “Is dapagliflozin aDAPtAble to treating reduced EF heart failure?” iForumRx commentary, podcast on DAPA-HF trial. December 2019.
    • Munjy L, Bethishou L, Andraos J. “Shingrix Revaccination and Vaccination in Vulnerable Populations”. Pharmacy Times. March 2019.